한글목차

미국의 체외진단(IVD) 시장은 2033년까지 완만한 성장이 예상됩니다. 만성 질환과 감염증 증가, 고령화의 진전, 「가치관에 근거한 의료」로의 이동이, 진단 정밀도의 향상과 소요 시간의 단축을 실현하는 신규 검사나 자동화 IVD 시스템의 보급을 뒷받침합니다.

IVD 시장은 다양하며 여러 시장 부문이 있습니다.

• 어떤 검사 시장이 정체되고 있는가?
• 기술 혁신의 여지가 있는 것은 어떤 검사 시장인가?
• 디지털 건강 기술은 이러한 부문에 어떻게 통합되는가?

검사 시장은 어떻게 성장할 것으로 예상되는가?

• 예측기간을 통해 가장 높은 성장을 이루는 검사는?
• 새로운 검사의 채택은 IVD 시장에 어떤 영향을 미치는가?

IVD경쟁 구도은 역동적입니다.

• 이 분야에서의 다국적기업과 중소기업의 전략의 차이는?
• 검사 시설이 IVD 제조업체를 인수 대상으로 선택할 때 고려해야 할 주요 구매 기준이란?
• 고정화가 진행된 시장에서 각 기업은 어떻게 차별화하는가?

본 보고서에서는 미국의 체외진단(IVD) 시장에 대해 분석하여 전체 시장 동향 전망(2019-2033년), 제품 카테고리별 상세 동향, 시장 경쟁 구도(주요 기업의 시장 점유율등) 주요 시장 촉진· 억제요인, 기술 혁신의 영향 등의 정보를 전해드립니다.

목차

미국

개요

주요 요약

주요 보고서 업데이트 내역

체외 진단제(IVD) 시장

• 시장 개요
• 시장의 정의
• 시장 예측 데이터
• 시장 점유율
• 경쟁 인사이트
  • Roche
  • Abbott Laboratories
  • 기타 주요 경쟁업체
  • 모든 경쟁업체에 영향을 미치는 요인

임상 화학 검사 시장

• 시장 개요
• 시장의 정의
• 시장 예측 데이터
  • 일반 화학 테스트
  • 당뇨병 검사
  • 치료 약물 모니터링 검사
  • 약물 남용 검사
  • 특정 단백질 검사
  • 심장 마커
  • 혈액가스
• 시장 점유율
• 경쟁 인사이트
  • 미국의 임상 화학 검사의 경쟁 인사이트
  • 모든 경쟁업체에 영향을 미치는 요인

면역 측정 검사 시장

• 시장 개요
• 시장의 정의
• 시장 예측 데이터
  • 알레르기 검사
  • 빈혈 검사
  • 뼈대사검사
  • 심장 마커 검사
  • 불임증/호르몬 검사
  • 감염증 검사
  • 특정 단백질
  • 갑상선 검사
  • 종양 마커 검사
• 시장 점유율
• 경쟁 인사이트
  • 미국의 면역 측정 검사의 경쟁 인사이트
  • 모든 경쟁업체에 영향을 미치는 요인

미생물 검사 시장

• 시장 개요
• 시장의 정의
• 시장 예측 데이터
  • 병리 배양 검사
  • 혈액 배양 검사
  • 식별/항생제 감수성 시험
• 시장 점유율
• 경쟁 인사이트
  • 미국의 미생물학 시험의 경쟁 인사이트

혈액검사·응고검사시장

• 시장 개요
• 시장의 정의
• 시장 예측 데이터
  • 일반 스크리닝 및 항응고 모니터링 검사
  • 프로트롬빈 시간 검사
  • D-Dimer 검사
  • 피브린 형성 및 분해 시험
• 시장 점유율
• 경쟁 인사이트
  • 미국의 혈액 검사·응고 검사의 경쟁 인사이트

분자진단 검사 시장

• 시장 개요
• 시장의 정의
• 시장 예측 데이터
  • 감염증 검사
• 시장 점유율
• 경쟁 인사이트
  • 미국의 분자진단 검사의 경쟁 인사이트

부록

영문목차

The US IVD market is expected to grow moderately through 2033, driven by the increasing prevalence of chronic and infectious diseases, the expanding aging population, and the shift toward value-based healthcare, which will fuel the uptake of novel tests and automated IVD systems that can offer improved diagnostic accuracy and reduced turnaround time.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IVDs in the US from 2019 through 2033.

The IVD market is diverse, with multiple market segments.

• Which test markets are stagnant?
• Which test markets are open to innovation?
• How will digital health technology be integrated into these segments?

How are the test markets expected to grow?

• Which tests will experience the highest growth throughout the forecast period?
• How will the adoption of newer tests affect the IVD market?

The IVD competitive landscape is dynamic.

• How do strategies differ between MNCs and smaller companies in this space?
• What are the key purchasing criteria laboratories consider when selecting an IVD manufacturer?
• How do competitors differentiate themselves in an entrenched market?

Table of Contents

United States

Abstract

Executive Summary

• COVID-19 Updates
• Market Highlights
• Competitive Highlights
• Market Developments
• Procedures Covered
• Products Covered

Key Report Updates

In Vitro Diagnostics Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
• Market Shares
• Competitive Insights
  • Roche
  • Abbott Laboratories
  • Other Key Competitors
  • Factors Affecting All Competitors
• Market Developments

Clinical Chemistry Test Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
  • General Chemistry Tests
  • Diabetes Tests
  • Therapeutic Drug Monitoring Tests
  • Drug of Abuse Testing
  • Specific Protein Tests
  • Cardiac Marker
  • Blood Gas
• Market Shares
• Competitive Insights
  • US Clinical Chemistry Test Competitive Insights
  • Factors Affecting All Competitors

Immunoassay Test Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
  • Allergy Tests
  • Anemia Tests
  • Bone Metabolism Tests
  • Cardiac Marker Tests
  • Fertility/Hormone Tests
  • Infectious Disease Tests
  • Specific Protein
  • Thyroid Tests
  • Tumor Marker Tests
• Market Shares
• Competitive Insights
  • US Immunoassay Test Competitive Insights
  • Factors Affecting All Competitors

Microbiology Test Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
  • Pathological Culture Tests
  • Blood Culture Tests
  • Identification/Antibiotic Susceptibility Testing
• Market Shares
• Competitive Insights
  • US Microbiology Test Competitive Insights

Hematology and Coagulation Test Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
  • General Screening and Anticoagulation Monitoring Tests
  • Prothrombin Time Tests
  • D-Dimer Tests
  • Fibrin Formation and Degradation Tests
• Market Shares
• Competitive Insights
  • US Hematology and Coagulation Test Competitive Insights

Molecular Diagnostic Test Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
  • Infectious Disease Tests
• Market Shares
• Competitive Insights
  • US Molecular Diagnostic Test Competitive Insights

Appendix

• Abbreviations
• Bibliography

Tables and Figures

• IVD Market, by Application, US (USD), 2019-2033
• IVD Market Landscape, US (USD), 2023 and 2033
• IVD Test Revenue Market Share Rankings, by Application, US, 2023
• Competitive Insights
• Companies Mentioned
• Recent Events in the IVD Market, US
• IVD Procedures Covered, US
• IVD Products1 Covered, US
• US In Vitro Diagnostics Market Drivers
• US In Vitro Diagnostics Market Limiters
• IVD Market, by Application, US (USD), 2019-2033
• IVD Market, by Product Type, US (USD), 2019-2033
• IVD Market, by Setting, US (USD), 2019-2033
• IVD Market, by Application, US (USD), 2019-2033
• IVD Test Market, by Application, US (USD), 2019-2033
• IVD Instrumentation Market, by Application, US (USD), 2019-2033
• IVD Test Revenue Market Shares, US, 2023
• IVD Test Revenue Market Shares, by Application, US, 2023
• Roche Competitive Insights
• Abbott Laboratories Competitive Insights
• Competitive Insights for Other Key Competitors
• Recent Events in the IVD Market, US
• US Clinical Chemistry Test Market Drivers
• US Clinical Chemistry Test Market Limiters
• Clinical Chemistry Test Market, by Product Type, US (USD), 2019-2033
• Clinical Chemistry Test Market, by Product Type, US (USD), 2019-2033
• Clinical Chemistry Test Market, by Setting, US (USD), 2019-2033
• Clinical Chemistry Test Market, by Test Type, US (USD), 2019-2033
• Alanine Aminotransferase Tests, by Setting, US, 2019-2033
• Alkaline Phosphatase Tests, by Setting, US, 2019-2033
• Aspartate Aminotransferase Tests, by Setting, US, 2019-2033
• Bilirubin Tests, by Setting, US, 2019-2033
• Calcium Tests, by Setting, US, 2019-2033
• Comprehensive Metabolic Panel Tests, by Setting, US, 2019-2033
• Creatinine Tests, by Setting, US, 2019-2033
• Electrolyte Panel Tests, by Setting, US, 2019-2033
• Hepatic Panel Tests, by Setting, US, 2019-2033
• Human Chorionic Gonadotropin Tests, by Setting, US, 2019-2033
• Lactate Tests, by Setting, US, 2019-2033
• Lactate Dehydrogenase Tests, by Setting, US, 2019-2033
• Lipase Tests, by Setting, US, 2019-2033
• Lipid Panel Tests, by Setting, US, 2019-2033
• Magnesium Tests, by Setting, US, 2019-2033
• Metabolic Panel including Total Calcium Tests, by Setting, US, 2019-2033
• Phosphorus Tests, by Setting, US, 2019-2033
• Potassium Tests, by Setting, US, 2019-2033
• Total Protein Tests, by Setting, US, 2019-2033
• Uric Acid Tests, by Setting, US, 2019-2033
• Other General Chemistry Tests, by Setting, US, 2019-2033
• Blood Glucose (Non-Reagent-Strip) Tests, by Setting, US, 2019-2033
• Blood Glucose Reagent Strip Tests, by Setting, US, 2019-2033
• Glucose Tolerance Tests, by Setting, US, 2019-2033
• HbA1c Tests, by Setting, US, 2019-2033
• Insulin Tests, by Setting, US, 2019-2033
• Microalbumin Quantitative Tests, by Setting, US, 2019-2033
• Urine Glucose Tests, by Setting, US, 2019-2033
• Other Diabetes Tests, by Setting, US, 2019-2033
• Carbamazepine Tests, by Setting, US, 2019-2033
• Cyclosporine Tests, by Setting, US, 2019-2033
• Digoxin Tests, by Setting, US, 2019-2033
• Phenobarbital Tests, by Setting, US, 2019-2033
• Phenytoin (Total) Tests, by Setting, US, 2019-2033
• Tacrolimus Tests, by Setting, US, 2019-2033
• Theophylline Tests, by Setting, US, 2019-2033
• Valproic Acid (Total) Tests, by Setting, US, 2019-2033
• Vancomycin Tests, by Setting, US, 2019-2033
• Other TDM Tests, by Setting, US, 2019-2033
• Ethanol Tests, by Setting, US, 2019-2033
• Acetaminophen Tests, by Setting, US, 2019-2033
• Salicylate Tests, by Setting, US, 2019-2033
• Antinuclear Antibody Tests, by Setting, US, 2019-2033
• Haptoglobin Tests, by Setting, US, 2019-2033
• Homocysteine Tests, by Setting, US, 2019-2033
• Prealbumin Tests, by Setting, US, 2019-2033
• Rheumatoid Factor Tests, by Setting, US, 2019-2033
• Somatomedin Tests, by Setting, US, 2019-2033
• Other Specific Protein Tests, by Setting, US, 2019-2033
• Apolipoprotein Tests, by Setting, US, 2019-2033
• Cholesterol Tests, by Setting, US, 2019-2033
• C-Reactive Protein Tests, by Setting, US, 2019-2033
• High Sensitivity C-Reactive Protein Tests, by Setting, US, 2019-2033
• Low Density Lipoprotein Tests, by Setting, US, 2019-2033
• Triglyceride Tests, by Setting, US, 2019-2033
• Other Cardiac Marker Tests, by Setting, US, 2019-2033
• Arterial Blood Gas Tests, by Setting, US, 2019-2033
• Chloride Tests, by Setting, US, 2019-2033
• Urea Nitrogen Tests, by Setting, US, 2019-2033
• Other Blood Gas Tests, by Setting, US, 2019-2033
• Clinical Chemistry Test Revenue Market Shares, US, 2023
• Clinical Chemistry Test Revenue Market Shares, by Product Type, US, 2023
• US Immunoassay Test Market Drivers
• US Immunoassay Test Market Limiters
• Immunoassay Test Market, by Product Type, US (USD), 2019-2033
• Immunoassay Test Market, by Product Type, US (USD), 2019-2033
• Immunoassay Test Market, by Setting, US (USD), 2019-2033
• Immunoassay Test Market, by Test Type, US (USD), 2019-2033
• Allergy IgA, IgD, IgG, IgM Tests, by Setting, US, 2019-2033
• Allergy IgE Tests, by Setting, US, 2019-2033
• Immunoglobulin Subclasses Tests, by Setting, US, 2019-2033
• Erythropoietin Tests, by Setting, US, 2019-2033
• Ferritin Tests, by Setting, US, 2019-2033
• Intrinsic Factor Antibody Tests, by Setting, US, 2019-2033
• Iron Tests, by Setting, US, 2019-2033
• Iron Binding Capacity Tests, by Setting, US, 2019-2033
• Vitamin B-12 Tests, by Setting, US, 2019-2033
• HGH Tests, by Setting, US, 2019-2033
• Parathormone Tests, by Setting, US, 2019-2033
• Vitamin D 25 Hydroxy Tests, by Setting, US, 2019-2033
• Creatine Kinase Tests, by Setting, US, 2019-2033
• CK-MB Tests, by Setting, US, 2019-2033
• BNP Tests, by Setting, US, 2019-2033
• Troponin Tests, by Setting, US, 2019-2033
• ACTH Tests, by Setting, US, 2019-2033
• Estradiol Tests, by Setting, US, 2019-2033
• FSH Tests, by Setting, US, 2019-2033
• LH Tests, by Setting, US, 2019-2033
• Progesterone Tests, by Setting, US, 2019-2033
• Prolactin Tests, by Setting, US, 2019-2033
• Testosterone Tests, by Setting, US, 2019-2033
• Other Fertility/Hormone Tests, by Setting, US, 2019-2033
• Acute Hepatitis Tests, by Setting, US, 2019-2033
• CMV Tests, by Setting, US, 2019-2033
• Epstein-Barr Virus Tests, by Setting, US, 2019-2033
• Hepatitis A Tests, by Setting, US, 2019-2033
• Hepatitis B Tests, by Setting, US, 2019-2033
• Hepatitis C Tests, by Setting, US, 2019-2033
• HIV-1/HIV-2 Tests, by Setting, US, 2019-2033
• HSV Tests, by Setting, US, 2019-2033
• HSV Type 2 Tests, by Setting, US, 2019-2033
• HTLV or HIV Tests, by Setting, US, 2019-2033
• Influenza A/B Tests, by Setting, US, 2019-2033
• Lyme Disease Tests, by Setting, US, 2019-2033
• Microsomal Antibodies Tests, by Setting, US, 2019-2033
• Nephelometry Tests, by Setting, US, 2019-2033
• Parvovirus Tests, by Setting, US, 2019-2033
• Respiratory Syncytial Virus Tests, by Setting, US, 2019-2033
• Rotavirus Tests, by Setting, US, 2019-2033
• Rubella Tests, by Setting, US, 2019-2033
• Treponema Pallidum Tests, by Setting, US, 2019-2033
• Varicella-Zoster Virus Tests, by Setting, US, 2019-2033
• Other Infectious Disease Tests, by Setting, US, 2019-2033
• Albumin Tests, by Setting, US, 2019-2033
• Alpha-1 Antitrypsin Tests, by Setting, US, 2019-2033
• Gamma-Glutamyl Transferase Tests, by Setting, US, 2019-2033
• Thyroxine (Free) Tests, by Setting, US, 2019-2033
• Thyroglobulin Tests, by Setting, US, 2019-2033
• Thyroid (T3) Tests, by Setting, US, 2019-2033
• Thyroid (T3 or T4) Tests, by Setting, US, 2019-2033
• Thyroxine (Total) Tests, by Setting, US, 2019-2033
• TSH Tests, by Setting, US, 2019-2033
• Alpha-Fetoprotein Serum Tests, by Setting, US, 2019-2033
• Beta-2 Microglobulin Tests, by Setting, US, 2019-2033
• CA 125 Tests, by Setting, US, 2019-2033
• CA 15-3 Tests, by Setting, US, 2019-2033
• CA 19-9 Tests, by Setting, US, 2019-2033
• Carcinoembryonic Antigen Tests, by Setting, US, 2019-2033
• PSA (Free) Tests, by Setting, US, 2019-2033
• PSA (Total) Tests, by Setting, US, 2019-2033
• Other Tumor Marker Tests, by Setting, US, 2019-2033
• Immunoassay Test Revenue Market Shares, US, 2023
• Immunoassay Test Revenue Market Shares, by Product Type, US, 2023
• US Microbiology Test Market Drivers
• US Microbiology Test Market Limiters
• Microbiology Test Market, by Product Type, US (USD), 2019-2033
• Microbiology Test Market, by Product Type, US (USD), 2019-2033
• Microbiology Test Market, by Setting, US (USD), 2019-2033
• Microbiology Test Market, by Test Type, US (USD), 2019-2033
• Salmonella and Shigella (Stool Culture) Tests, by Setting, US, 2019-2033
• Other Pathogen (Stool Culture) Tests, by Setting, US, 2019-2033
• Mycobacteria Culture Tests, by Setting, US, 2019-2033
• Aerobic Bacterial Culture (Non-Urine, -Blood, -Stool) Tests, by Setting, US, 2019-2033
• Anaerobic Bacterial Culture (Non-Urine, -Blood, -Stool) Tests, by Setting, US, 2019-2033
• Urine Bacteria Culture Tests, by Setting, US, 2019-2033
• Blood Culture Tests, by Setting, US, 2019-2033
• Aerobic Culture Identification Tests, by Setting, US, 2019-2033
• Anaerobic Culture Identification Tests, by Setting, US, 2019-2033
• Immunologic Culture Identification Tests, by Setting, US, 2019-2033
• MIC Tests, by Setting, US, 2019-2033
• Microbe Susceptible Disk Tests, by Setting, US, 2019-2033
• Presumptive Pathogenic Organisms Culture Tests, by Setting, US, 2019-2033
• Yeast Identification Tests, by Setting, US, 2019-2033
• Other ID/AST Tests, by Setting, US, 2019-2033
• Microbiology Test Revenue Market Shares, US, 2023
• Microbiology Test Revenue Market Shares, US, 2023
• US Hematology and Coagulation Test Market Drivers
• Hematology and Coagulation Test Market, by Product Type, US (USD), 2019-2033
• Hematology and Coagulation Test Market, by Product Type, US (USD), 2019-2033
• Hematology and Coagulation Test Market, by Setting, US (USD), 2019-2033
• Hematology and Coagulation Test Market, by Test Type, US (USD), 2019-2033
• Automated Platelet Count Tests, by Setting, US, 2019-2033
• Blood Smear with Differential White Blood Cell Count Tests, by Setting, US, 2019-2033
• Complete CBC Automated Tests, by Setting, US, 2019-2033
• Complete CBC with Automated White Blood Cell Count Tests, by Setting, US, 2019-2033
• Erythrocyte Sedimentation Rate Tests, by Setting, US, 2019-2033
• Hematocrit Tests, by Setting, US, 2019-2033
• Hemoglobin Tests, by Setting, US, 2019-2033
• Leukocyte Tests, by Setting, US, 2019-2033
• Red Blood Cell Count Tests, by Setting, US, 2019-2033
• Reticulocyte Tests, by Setting, US, 2019-2033
• Sickle Cell Screen Tests, by Setting, US, 2019-2033
• Transferrin Tests, by Setting, US, 2019-2033
• Other General Screening and Anticoagulation Monitoring Tests, by Setting, US, 2019-2033
• Prothrombin Time Tests, by Setting, US, 2019-2033
• D-Dimer Tests, by Setting, US, 2019-2033
• aPTT Tests, by Setting, US, 2019-2033
• Fibrinogen Tests, by Setting, US, 2019-2033
• Hematology and Coagulation Test Revenue Market Shares, US, 2023
• Hematology and Coagulation Test Revenue Market Shares, by Product Type, US, 2023
• US Molecular Diagnostic Test Market Drivers
• US Molecular Diagnostic Test Market Limiters
• MDx Test Market, by Product Type, US (USD), 2019-2033
• MDx Test Market, by Product Type, US (USD), 2019-2033
• MDx Test Market, by Setting, US (USD), 2019-2033
• Chlamydia Tests, by Setting, US, 2019-2033
• Clostridium Difficile Tests, by Setting, US, 2019-2033
• Gonorrhea Tests, by Setting, US, 2019-2033
• Hepatitis C Tests, by Setting, US, 2019-2033
• HIV-1 Tests, by Setting, US, 2019-2033
• HPV Tests, by Setting, US, 2019-2033
• HSV Tests, by Setting, US, 2019-2033
• Staphylococcus Aureus Tests, by Setting, US, 2019-2033
• Streptococcus Group A Tests, by Setting, US, 2019-2033
• Unspecified Infectious Agent Tests, by Setting, US, 2019-2033
• Other Infectious Disease Tests, by Setting, US, 2019-2033
• MDx Test Revenue Market Shares, US, 2023
• MDx Test Revenue Market Shares, by Product Type, US, 2023